To access this material please log in or register

Register Authorize

Transcatheter Implantation of Mitral Valve Prostheses: Current Status of the Problem

Zhuravleva I. Yu., Bogachev-Prokophiev A. V., Demidov D. P., Karaskov A. M.
Siberian Federal Biomedical Research Center named after acad. E.N. Meshalkina, Novosibirsk, Russia

Keywords: mitral valve disease; transcatheter mitral valve implantation

DOI: 10.18087/cardio.2017.8.10018

Mitral valve disease is highly prevalent and quickly leads to development of severe heart failure. Mitral valve disease of degenerative or ischemic etiology affects 7.5 and 9.3% of population older than 65 and 75 years, respectively. “Open” (with cardiopulmonary bypass) surgical repair or valve replacement are not possible in almost half of affected patients because of their complications and concomitant diseases responsible for extremely high risk of these interventions. In the last decade, minimally invasive endovascular technology – transcatheter aortic valve implantation (TAVI) – has been widely introduced for correction of aortic valve disease in similar category of patients. However, transcatheter mitral valve implantation (TMVI) has been developed just during recent couple of years.
  1. Nkomo V.T., Gardin J.M., Skelton T.N. et al. Burden of valvular heart diseases: a population‑based study. Lancet 2006;368:1005–1011.
  2. Mylotte D., Piazza N. Transcatheter mitral valve implantation: a brief review. EuroIntervention 2015;11Suppl. W:W67–70. doi: 10.4244/EIJV11SWA19
  3. Mirabel M., Iung B., Baron G. et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358–1365. doi:10.1093/eurheartj/ehm156
  4. Maisano F., Buzzatti N., Taramasso M., Alfieri O. Mitral Transcatheter Technologies. Rambam Maimonides Med J 2013;4(3):e0015. doi:10.5041/RMMJ.10115
  5. Ramlawi B., Gammie J.S. Mitral valve surgery: current minimally invasive and transcatheter options. Methodist Debakey Cardiovasc J 2016;12(1):20–26. doi: 10.14797/mdcj‑12‑1‑20
  6. The distribution of population in the Russian Federation by sex and age groups on 1 January 2016. (Распределение численности населения Российской Федерации по полу и возрастным группам на 1 января 2016 года). http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/
  7. World Health Statistics‑2016. Global Health Observatory (GHO) data. World Health Organization http://www.who.int/gho/publi‑cations/world_health_statistics/en/
  8. Bokerija L. A., Gudkova R. G. Cardiovascular surgery – 2015: Diseases and congenital anomalies of the circulatory system. M.: NCSSH im. A.N. Bakuleva; 2016. 226p. Russian (Бокерия Л. А., Гудкова Р. Г. Сердечно‑сосудистая хирургия – 2015: Болезни и врожденные аномалии системы кровообращения. М.: НЦССХ им. А.Н.Бакулева; 2016. 226 с.)
  9. Bapat V. In vitro evaluation of valve‑in-valve combinations using a SAPIEN XT valve implanted within PERIMOUNT and Magna Ease pericardial bioprostheses. EuroIntervention 2016;11:e1291–e1301. doi: 10.4244/EIJV11I11A251
  10. Bouleti C., Fassa A.‑A., Himbert D. et al. Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty. JACC: Cardiovasc Interv 2015;8(1 Pt A):83–91. doi: 10.1016/j.jcin.2014.07.026
  11. Gallo M., Dvir D., Demertzis S. et al. Transcatheter valve‑in‑valve implantation for degenerated bioprosthetic aortic and mitral valves. Expert Rev Med Devices 2016;13(8):749–758. doi:10.1080/17434440.2016.1207521
  12. Tchetche D., Van Mieghem N.M. New‑generation TAVI devices: description and specifications. EuroIntervention 2014;10(Suppl U):U90–100. doi: 10.4244/EIJV10SUA13
  13. Cribier A., Durand E., Eltchaninoff H. Patient selection for TAVI in 2014: is it justified to treat low‑or intermediate‑risk patients? The cardiologist’s view. EuroIntervention 2014;10(Suppl U):U16–21. doi: 10.4244/EIJV10SUA3
  14. Kappetein A.P., Osnabrugge R .L.J., Head S.J. Patient selection for TAVI in 2014: is there a justification for treating low‑or intermediate‑risk patients? The surgeon’s view. EuroIntervention 2014;10(Suppl U):U11–15. doi: 10.4244/EIJV10SUA2
  15. Zamorano J.L., González‑Gómez A., Lancellotti P. Mitral valve anatomy: implications for transcatheter mitral valve interventions. EuroIntervention 2014;10(Suppl U): U106‑11. doi: 10.4244/EIJV10SUA15
  16. Gonzalez‑Gomez A., Fernandez‑Santos S., Fernandez‑Golfin C., Zamorano J.L. Mitral valve anatomy: preprocedural screening and imaging techniques. EuroIntervention 2015;11:W32–6. doi: 10.4244/EIJV11SWA8
  17. Blanke P., Naoum C., Dvir D. et al. Predicting LVOT Obstruction in Transcatheter Mitral Valve Implantation: Concept of the Neo‑LVOT. JACC Cardiovasc Imaging 2016;. pii: S1936‑878X(16)00039‑5. doi: 10.1016/j.jcmg.2016.01.005
  18. Mak G.J., Blanke P., Ong K. et al. Three‑Dimensional Echocardiography Compared With Computed Tomography to Determine Mitral Annulus Size Before Transcatheter Mitral Valve Implantation. Circ. Cardiovasc. Imaging 2016;9(6)pii: e004176. doi: 10.1161/CIRCIMAGING.115.004176
  19. Taramasso M., Candreva A., Pozzoli A. et al. Current challenges in interventional mitral valve treatment. J Thorac Dis 2015;7(9):1536–1542. doi: 10.3978/j.issn.2072‑1439.2015.04.58
  20. Naoum C., Leipsic J., Cheung A. et al. Mitral Annular Dimensions and Geometry in Patients With Functional Mitral Regurgitation and Mitral Valve Prolapse: Implications for Transcatheter Mitral Valve Implantation. J Am Coll Cardiol Img 2016;9(3):269–280. doi:10.1016/j.jcmg.2015.08.022
  21. Paradis J.‑M., Del Trigo M., Puri R., Rodés‑Cabau J. Transcatheter Valve‑in‑Valve and Valve‑in‑Ring for Treating Aortic and Mitral Surgical Prosthetic Dysfunction. . J Am Coll Cardiol 2015;66(18):2019–2037. doi: 10.1016/j.jacc.2015.09.015
  22. Conradi L., Silaschi M., Seiffert M. et al. Transcatheter valve‑in‑valve therapy using 6 different devices in 4 anatomic positions: Clinical outcomes and technical considerations. J Thorac Cardiovasc Surg 2015;150:1557–1567. doi: 10.1016/j.jtcvs.2015.08.065
  23. Cheung A., Webb J.G., Barbanti M. et al. 5‑year experience with transcatheter transapical mitral valve‑in‑valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol 2013;61:1759–1766. doi: 10.1016/j.jacc.2013.01.058
  24. Seiffert M., Conradi L., Baldus S. et al. Transcatheter mitral valve‑in‑valve implantation in patients with degenerated bioprostheses. JACC Cardiovasc. Interv 2012;5:341–349. doi: 10.1016/j.jcin.2011.12.008
  25. Wilbring M., Alexiou K., Tugtekin S.M. et al. Transapical transcatheter valve‑in‑valve implantation for deteriorated mitral valve bioprostheses. Ann Thorac Surg 2013;95:111–117. doi: 10.1093/ejcts/ezs680
  26. Puri R., Abdul‑Jawad Altisent O., del Trigo M. et al. Transcatheter Mitral Valve Implantation for Inoperable Severely Calcified Native Mitral Valve Disease: A Systematic Review. Catheter Cardiovasc Interv 2016;87:540–548. doi: 10.1002/ccd.26262
  27. Feldman T. Transcatheter mitral valve interventions: current status and future perspective EuroIntervention 2012;8:Q53–59. doi: 10.4244/EIJV8SQA10
  28. Herrmann H.C., Maisano F. Transcatheter Therapy of Mitral Regurgitation. Circulation 2014;130:1712–1722. doi: 10.1161/CIRCULATIONAHA.114.009881
  29. Kheradvar A., Groves E.M., Simmons C.A. et al. Emerging Trends in Heart Valve Engineering: Part III. Novel Technologies for Mitral Valve Repair and Replacement. Ann Biomed Engineer 2015;43(4):858–870. doi:10.1007/s10439‑014‑1129‑y
  30. Romeo F., Cammalleria V., Ruvolo G. et al. Transcatheter mitral valve implantation for mitral regurgitation: clinical case description and literature review. J Cardiovasc Med 2016;17:85–91. doi:10.2459/JCM.0000000000000328
  31. Baumgarten H., Squiers J.J., Arsalan M. et al. Defining the clinical need and indications: who are the right patients for transcatheter mitral valve replacement. J Cardiovasc Surg (Torino) 2016;57(3):352–359.
  32. Stone G.W., Vahanian A.S., Adams D.H. et al. Mitral Valve Academic Research Consortium (MVARC). Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium. J Am Coll Cardiol 2015;66(3):278–307. doi: 10.1016/j.jacc.2015.05.046
  33. Stone G.W., Adams D.H., Abraham W.T. et al. Mitral Valve Academic Research Consortium (MVARC). Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement. Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. J Am Coll Cardiol 2015;66(3):308–321. doi: 10.1016/j.jacc.2015.05.049
  34. Maisano F., Alfieri O., Banai S. et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J 2015;36(26):1651–1660. doi:10.1093/eurheartj/ehv123
  35. Grasso C., Capodanno D., Tamburino C., Ohno Y. Current Status and Clinical Development of Transcatheter Approaches for Severe Mitral Regurgitation Circ J 2015;79:1164–1171. doi: 10.1253/circj.CJ‑15‑0447
  36. Preston‑Maher G.L.М., Torii R., Burriesci G. A Technical Review of Minimally Invasive Mitral Valve Replacements. Cardiovasc Eng Technol 2015;6(2):174–184. doi: 10.1007/s13239‑014‑0203‑9
  37. De Backer O., Piazza N., Banai S. et al. Percutaneous Transcatheter Mitral Valve Replacement: An Overview of Devices in Preclinical and Early Clinical Evaluation. Circ Cardiovasc Interv 2014;7(3):400–409. doi: 10.1161/CIRCINTERVENTIONS.114.001607
  38. Ussia G.P., Quadri A., Cammalleri V. et al. Percutaneous transfemoral‑transseptal implantation of a second‑generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30‑day follow‑up. EuroIntervention 2016;11:1126–1131. doi: 10.4244/EIJY15M09_01
  39. Barbanti M., Tamburino C. Transcatheter mitral valve implantation: CardiAQ. EuroIntervention 2016;12 (Suppl Y):Y73‑4. doi: 10.4244/EIJV12SYA19
  40. Moat N.E., Duncan A., Quarto C. Transcatheter mitral valve implantation: Tendyne. EuroIntervention 2016;12 (Suppl Y):Y75–77. doi: 10.4244/EIJV12SYA20
  41. Cheung A., Banai S. Transcatheter mitral valve implantation: Tiara. EuroIntervention 2016;12 (Suppl Y):Y70–72. doi: 10.4244/EIJV12SYA18
  42. Lange R., Piazza N. HighLife transcatheter mitral valve replacement EuroIntervention 2016;12 (Suppl Y):Y81–83. doi: 10.4244/EIJV12SYA22
  43. Bapat V., Lim Z.Y., Boix R., Pirone F. The Edwards Fortis transcatheter mitral valve implantation system EuroIntervention 2015;11 (Suppl W):W73–75. doi: 10.4244/EIJV11SWA21
  44. Altisent O.A.‑J., Dumont E., Dagenais F. et al. Transcatheter Mitral Valve Implantation With the FORTIS Device: Insights Into the Evaluation of Device Success. JACC: Cardiovasc Interv 2015;8(7):994–995. doi.org/10.1016/j.jcin.2015.01.036
  45. Testa L., Latib A., Montone R .A., Bedogni F. Transcatheter mitral valve regurgitation treatment: State of the art and a glimpse to the future. J Thorac Cardiovasc Surg 2016;152:319–327. doi.org/10.1016/j.jtcvs.2016.04.055
  46. Piazza N., Bolling S., Moat N., Treede H. Medtronic transcatheter mitral valve replacement. EuroIntervention 2014;10(Suppl U):U112–114. doi: 10.4244/EIJV10SUA16
  47. Piazza N., Treede H., Moat N. et al. The Medtronic transcatheter mitral valve implantation system. EuroIntervention 2015;11(W):W80–1. doi: 10.4244/EIJV11SWA24
  48. Meredith I., Bapat V., Morriss J., et al. Intrepid transcatheter mitral valve replacement system: technical and product description. EuroIntervention 2016;12 (Suppl Y):Y78–80. doi: 10.4244/EIJV12SYA21
  49. Abdelghani M., Onuma Y., Zeng Y. et al. The Sino Medical AccuFit transcatheter mitral valve implantation system. EuroIntervention 2015;11(W):W84–85. doi: 10.4244/EIJV11SWA26
  50. Jain R., Algahim M.F., Bajwa T.K. et al. Native Mitral Stenosis Treated With Transcatheter Mitral Valve Replacement. Ann Thorac Surg 2016;101:e75–77. doi.org/10.1016j.athoracsur.2015.09.020
  51. Guerrero M., Dvir D., Himbert D. et al. Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. JACC: Cardiovasc Interv 2016;9(13):1361–1371. doi.org/10.1016/j.jcin.2016.04.022
  52. Ferrari E., Dvir D., Guerrerod M. Transcatheter mitral valve replacement in degenerated calcified native mitral valves: is the currently available technology suitable? Eur J Cardiothorac Surg 2016; May 30 (1–5). doi:10.1093/ejcts/ezw188
  53. Taramasso M., Maisano F. Transcatheter mitral valve interventions: pathophysiological considerations in choosing reconstruction versus transcatheter valve implantation. EuroIntervention 2015;11:W37–41. doi: 10.4244/EIJV11SWA9
  54. Pokorny S., Huenges K., Bähr T. et al. Transapical mitral valved stent implantation: Enhanced survival and decreased paravalvular leakages. Intern. J Cardiol 2014;175:418–424. doi.org/10.1016/j.ijcard.2014.06.007
  55. Boudjemline Y., Pineau E., Borenstein N. et al. New insights in minimally invasive valve replacement: description of a cooperative approach for the off‑pump replacement of mitral valves. Eur Heart J 2005;26:2013–2017. doi:10.1093/eurheartj/ehi307
  56. Walther T., Falk V., Dewey T. et al. Valve‑in‑a‑Valve Concept for Transcatheter Minimally Invasive Repeat Xenograft Implantation. J Am Coll Cardiol 2007;50:56–60. doi:10.1016/j.jacc.2007.03.030
  57. Webb J.G., Wood D.A., Ye J. et al. Transcatheter Valve‑in‑Valve Implantation for Failed Bioprosthetic Heart Valves. Circulation 2010;121:1848–1857. doi: 10.1161/CIRCULATIONAHA.109.924613
  58. Simonato M., Webb J., Kornowski R. et al. Transcatheter Replacement of Failed Bioprosthetic Valves Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve‑in‑Valve. Circ Cardiovasc Interv 2016;9:e003651. doi: 10.1161/CIRCINTERVENTIONS.115.003651
  59. Dvir D., Webb J. Mitral valve‑in‑valve and valve‑in‑ring: technical aspects and procedural outcomes. EuroIntervention 2016;12(Y):Y93–Y96. doi: 10.4244/EIJV12SYA25
  60. Blanke P., Dvir D., Cheung A. et al. Mitral Annular Evaluation With CT in the Context of Transcatheter Mitral Valve Replacement. JACC: Cardiovasc Imaging 2015;8(5):612–615. doi.org/10.1016/j.jcmg.2014.07.028
  61. Hamid N.B., Khalique O.K., Monaghan M.J. et al. Transcatheter Valve Implantation in Failed Surgically Inserted Bioprosthesis: Review and Practical Guide to Echocardiographic Imaging in Valve‑in‑Valve Procedures. JACC: Cardiovasc Imaging 2015;8(8):960–979. doi.org/10.1016/j.jcmg.2015.01.024
  62. Natarajan N., Patel P., Bartel T. et al. Peri‑procedural imaging for transcatheter mitral valve replacement. Cardiovasc Diagn Ther 2016;6(2):144–159. doi.org/10.21037cdt.2016.02.04
  63. Bergsland J., Mirtaheri P., Hiorth N., Fosse E. Review of the endovascular approach to mitral valve disease. Minimally Invasive Therapy 2015;24:282–288. doi: 10.3109/13645706.2015.1065891
  64. Coylewright M., Cabalka A.K., Malouf J.A. et al. Percutaneous mitral valve replacement using a transvenous, transseptal approach: transvenous mitral valve replacement. JACC Cardiovasc Interv 2015;8(6):850–857. doi: 10.1016/j.jcin.2015.01.028
  65. Sondergaard L., Brooks M. et al. Transcatheter mitral valve implantation via transapical approach: an early experience. Eur J Cardiothorac Surg 2015;48(6):873–877. doi:10.1093/ejcts/ezu546
  66. Bruschi G., Barosi A., Colombo P. et al. Direct Transatrial Transcatheter SAPIEN Valve Implantation Through Right Minithoracotomy in a Degenerated Mitral Bioprosthetic Valve. Ann Thorac Surg 2012;93:1708–1710. doi: 10.1016/j.athoracsur.2011.08.084
  67. Mazzitelli D., Bleiziffer S., Noebauer C. et al. Transatrial Antegrade Approach for Double Mitral and Tricuspid “Valve‑in‑Ring” Implantation. Ann Thorac Surg 2013;95:e25–27. doi: 10.1016/j.athoracsur.2012.09.092
  68. Cerillo A.G., Chiaramonti F., Murzi M., et al. Transcatheter valve in valve implantation for failed mitral and tricuspid bioprosthesis. Catheter Cardiovasc Interv 2011;78:987–995.
Zhuravleva I. Yu., Bogachev-Prokophiev A. V., Demidov D. P., Karaskov A. M. Transcatheter Implantation of Mitral Valve Prostheses: Current Status of the Problem. Kardiologiia. 2017;57(8):51–59.

To access this material please log in or register

Register Authorize
Ru En